HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Regulatory Round-Up: EFSA Scientific Opinions On Novel Foods, Vitamin K2 Health Claim

Executive Summary

Vitamin D mushroom powder, selenium- and chromium-enriched biomass of y. lipolytica and astaxanthin-based pink coloring are novel foods considered by the European Food Safety Authority's Authority’s Panel on Nutrition, Novel Foods and Food Allergens. The NDA also rejects a health claim for NattoPharma’s vitamin K2 food supplement, MenaQ7.

You may also be interested in...



US Plant-Sourced Food Additive Options For Vitamin D2 Expand To Mushroom Powder

FDA amends food additive regulations with Oakshire’s petition to use agaricus bisporus mushroom powder, produced using UV light treatment, as a source of vitamin D2 in foods and supplements.

CBD Self-Regulation? UK Trade Association Launches Three-Tier Certification System

HBW Insight speaks to the founder of the UK's Association for the Cannabinoid Industry, Steve Moore, about the organization's new three-tier certification system for CBD products marketed in the country, designed to mirror the EU Novel Foods approval process as well as recent local regulatory changes. 

US Firm Mile High Files CBD Novel Food Applications In EU

Colorado's Mile High Labs has filed novel food applications with both EFSA and the UK's FSA to ensure it can keep legally supplying its hemp-derived CBD to European customers.

Related Content

Topics

UsernamePublicRestriction

Register

LL1122113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel